The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

被引:312
作者
Graner, E
Tang, D
Rossi, S
Baron, A
Migita, T
Weinstein, LJ
Lechpammer, M
Huesken, D
Zimmermann, J
Signoretti, S
Loda, M [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02155 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02155 USA
[3] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/S1535-6108(04)00055-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cellular levels of key regulatory proteins are controlled via ubiquitination and subsequent degradation. Deubiquitinating enzymes or isopeptidases can potentially prevent targeted destruction of protein substrates through deubiquitination prior to proteasomal degradation. However, only one deubiquitinating enzyme to date has been matched to a specific substrate in mammalian cells and shown to functionally modify it. Here we show that the isopeptidase USP2a (ubiquitin-specific protease-2a) interacts with and stabilizes fatty acid synthase (FAS), which is often overexpressed in biologically aggressive human tumors. Further, USP2a is androgen-regulated and overexpressed in prostate cancer, and its functional inactivation results in decreased FAS protein and enhanced apoptosis. Thus, the isopeptidase USP2a plays a critical role in prostate cancer cell survival through FAS stabilization and represents a therapeutic target in prostate cancer.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 30 条
[1]   Fatty acid synthesis is essential in embryonic development:: Fatty acid synthase null mutants and most of the heterozygotes die in utero [J].
Chirala, SS ;
Chang, H ;
Matzuk, M ;
Abu-Elheiga, L ;
Mao, JQ ;
Mahon, K ;
Finegold, M ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6358-6363
[2]   Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion [J].
Clegg, DJ ;
Wortman, MD ;
Benoit, SC ;
McOsker, CC ;
Seeley, RJ .
DIABETES, 2002, 51 (11) :3196-3201
[3]   The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein [J].
DeSalle, LM ;
Latres, E ;
Lin, D ;
Graner, E ;
Montagnoli, A ;
Baker, RT ;
Pagano, M ;
Loda, M .
ONCOGENE, 2001, 20 (39) :5538-5542
[4]   Regulation of the G1 to S transition by the ubiquitin pathway [J].
DeSalle, LM ;
Pagano, M .
FEBS LETTERS, 2001, 490 (03) :179-189
[5]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[6]  
EGNER R, 1993, J BIOL CHEM, V268, P27269
[7]   Key role of mitochondria in cerulenin-mediated apoptosis [J].
Heiligtag, SJ ;
Bredehorst, R ;
David, KA .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (09) :1017-1025
[8]   Going malignant: the hypoxia-cancer connection in the prostate [J].
Hochachka, PW ;
Rupert, JL ;
Goldenberg, L ;
Gleave, M ;
Kozlowski, P .
BIOESSAYS, 2002, 24 (08) :749-757
[9]   Synthesis and antitumor activity of an inhibitor of fatty acid synthase [J].
Kuhajda, FP ;
Pizer, ES ;
Li, JN ;
Mani, NS ;
Frehywot, GL ;
Townsend, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3450-3454
[10]   Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology [J].
Kuhajda, FP .
NUTRITION, 2000, 16 (03) :202-208